GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Mckesson Corporation (MCK) [hlAlert]

Rating:
Outperform
MCK
up 290.17 %

Mckesson Corporation (MCK) rated Outperform with price target $60 by Robert W. Baird

Posted on: Wednesday,  Jul 29, 2009  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Mckesson Corporation (NYSE: MCK) on 07/29/2009, when the stock price was $50.97. Since
then, Mckesson Corporation has gained 290.17% as of 01/12/2016's recent price of $198.87.
If you would have followed this Robert W. Baird's recommendation on MCK, you would have gained 290.17% of your investment in 2358 days.

McKesson Corporation (McKesson) provides supply, information and care management products and services across the healthcare industry. The Company operates through two segments: The McKesson Distribution Solutions segment and The McKesson Technology Solutions segment. The McKesson Distribution Solutions segment distributes ethical drugs, medical-surgical supplies and equipment, and health and beauty care products throughout North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells pharmacy software and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other services.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/29/2009 8:25 AM Buy
None
50.97 60.00
as of 12/31/2009
1 Week up  16.53 %
1 Month up  18.04 %
3 Months up  22.93 %
1 YTD up  43.63 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy